Transplantation, Corneal Completed Phase 2 Trials for Basiliximab (DB00074)

Also known as: Corneal Transplantation

IndicationStatusPhase
DBCOND0072811 (Transplantation, Corneal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00409656Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty PatientsPrevention